Cancer Research

UC Davis Researchers Conduct a Broad Range of Research to Improve Treatments

UC Davis lung cancer physicians are continually seeking new ways to improve the effectiveness of lung cancer treatments while reducing unwanted side effects. They are investigating new methods to increase diagnostic accuracy, new anti-cancer agents, immune system biomarkers by which to develop more focused medications, and targeted therapies including immunotherapies to combat lung cancer and other thoracic malignancies. Other UC Davis physicians are studying tumor DNA, surgical outcomes, pain management, the body’s mechanisms that resist cancer therapy, and health care disparities in access to cancer treatment.

The Cancer Center’s Clinical Research Advisory Committee works closely with the Office of Clinical Research to ensure compliance with all federal, state and local guidelines and requirements.